Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 307

Similar articles for PubMed (Select 16720563)

1.

Intensive immunosuppression therapy for aplastic anemia associated with dyskeratosis congenita.

Al-Rahawan MM, Giri N, Alter BP.

Int J Hematol. 2006 Apr;83(3):275-6. No abstract available.

PMID:
16720563
2.
3.

Aplastic anemia associated with dyskeratosis congenita treated with antilymphocyte globulin and cyclosporine: a case report.

Huang HM, Yu WL, Huang YL, Hwang WS, Tsao CJ, Liu HS, Huang GC.

Chin Med J (Engl). 2005 May 5;118(9):790-2. No abstract available.

PMID:
15899147
4.

Unrelated stem cell transplantation for severe acquired aplastic anemia: improved outcome in the era of high-resolution HLA matching between donor and recipient.

Maury S, Balère-Appert ML, Chir Z, Boiron JM, Galambrun C, Yakouben K, Bordigoni P, Marie-Cardine A, Milpied N, Kanold J, Maillard N, Socié G; French Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC).

Haematologica. 2007 May;92(5):589-96.

5.

Ethical and policy lessons to be learned from a family with inherited bone marrow failure.

Ross LF.

Am J Med Genet A. 2008 Nov 1;146A(21):2715-8. doi: 10.1002/ajmg.a.32544. No abstract available.

PMID:
18924227
6.

Correction of bone marrow failure in dyskeratosis congenita by bone marrow transplantation.

Ghavamzadeh A, Alimoghadam K, Nasseri P, Jahani M, Khodabandeh A, Ghahremani G.

Bone Marrow Transplant. 1999 Feb;23(3):299-301.

7.

Interdisciplinary approach to treat dyskeratosis congenita associated with severe aplastic anemia: a case report.

Fernandes Gomes M, Pinheiro de Abreu P, de Freitas Banzi C, de Oliveira Nogueira T.

Spec Care Dentist. 2006 Mar-Apr;26(2):81-4.

PMID:
16681244
8.

Fatal diffuse capillaritis after hematopoietic stem-cell transplantation for dyskeratosis congenita despite low-intensity conditioning regimen.

Brazzola P, Duval M, Fournet JC, Gauvin F, Dalle JH, Champagne J, Champagne MA.

Bone Marrow Transplant. 2005 Dec;36(12):1103-5; author reply 1105. No abstract available.

PMID:
16205731
9.

[Evidence-based medicine for treatment of aplastic anemia in children].

Kojima S.

Rinsho Ketsueki. 2005 Jun;46(6):394-8. Review. Japanese. No abstract available.

PMID:
16447720
10.

[Clinico-laboratory variants of the course and results of therapy of hepatitis-associated aplastic anemias in children].

Novichkova GA, Maschan MA, Kravchenko EG, Baĭdil'dina DD, Bogacheva NIu, Goronkova OV, Zharikova LI, Litvinov DV, Solopova GG, Suntsova EV, Shneĭder MM, Khachatrian LA, Skorobogatova EV, Shipitsyna IP, Trakhtman PE, Balashov DN, Maschan AA.

Ter Arkh. 2007;79(7):57-61. Russian.

PMID:
17802792
11.

Pediatric hematopoietic stem cell transplantation in Taiwan.

Lin KH.

Transplant Proc. 1998 Nov;30(7):3477-80. No abstract available.

PMID:
9838527
12.

Allogeneic hematopoietic stem cell transplantation for patients with severe aplastic anemia following nonmyeloablative conditioning using 200-cGy total body irradiation and fludarabine.

Koh LP, Koh MB, Ng HY, Hwang WY, Goh YT, Linn YC, Ng HJ, Chuah CT, Tan KW, Loh YS, Tan DC, Tan PH, Tan PH.

Biol Blood Marrow Transplant. 2006 Aug;12(8):887-90. No abstract available.

13.

The benefit of ATG in immunosuppressive therapy of children with moderate aplastic anemia.

Jiang S, Wang Y, Shi W, Shao Y, Qiao X, Lin J, Kuang H, Xie X.

Pediatr Hematol Oncol. 2009 Jul-Aug;26(5):313-20. doi: 10.1080/08880010902771549.

PMID:
19579077
14.

[Efficacy of immunosuppressive therapy in children with acquired aplastic anemia].

Wang SC, Zou Y, Chen XJ, Yang WY, Liu TF, Zhang L, Chen YM, Guo Y, Zhu XF.

Zhonghua Er Ke Za Zhi. 2009 Jan;47(1):53-6. Chinese.

PMID:
19573384
15.

[Natural history of moderate aplastic anemia in children and effects of immunosuppressive therapy].

Qiao XH, Xie XT, Jiang SY, Shi W, Li W, Zhou JJ.

Zhonghua Er Ke Za Zhi. 2008 Dec;46(12):909-13. Chinese.

PMID:
19134253
16.

Improved prognosis for acquired aplastic anaemia.

Pitcher LA, Hann IM, Evans JP, Veys P, Chessells JM, Webb DK.

Arch Dis Child. 1999 Feb;80(2):158-62.

17.

[Treatment of acquired severe aplastic anemia in pediatric patients with immunosuppression and allogeneic stem cell hematopoietic transplant].

Barriga C F, Wietstruck P A, Becker K A, Zúñiga C P, Besa De C P, Alvarez Z M, Ocqueteau T M, Bertín C P.

Rev Med Chil. 2007 Nov;135(11):1421-8. doi: /S0034-98872007001100008. Epub 2008 Jan 16. Spanish.

18.

[Twenty years of severe aplastic anemia treatment at Department of Hematology, University Department of Medicine, Zagreb University Hospital Center, Zagreb, Croatia].

Mrsić M, Seiwerth RS, Labar B, Bogdanić V, Nemet D, Duraković N, Mikulić M, Sertić D, Aurer I, Radman I, Zupancić-Salek S.

Acta Med Croatica. 2009 Jun;63(3):209-14. Croatian.

PMID:
19827347
19.

Outcome of patients with acquired aplastic anemia given first line bone marrow transplantation or immunosuppressive treatment in the last decade: a report from the European Group for Blood and Marrow Transplantation (EBMT).

Locasciulli A, Oneto R, Bacigalupo A, Socié G, Korthof E, Bekassy A, Schrezenmeier H, Passweg J, Führer M; Severe Aplastic Anemia Working Party of the European Blood and Marrow Transplant Group.

Haematologica. 2007 Jan;92(1):11-8.

20.

TERC mutations in children with refractory cytopenia.

Ortmann CA, Niemeyer CM, Wawer A, Ebell W, Baumann I, Kratz CP.

Haematologica. 2006 May;91(5):707-8.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk